CERo Therapeutics Holdings Inc (NASDAQ:CERO) price on Friday, November 15, rose 52.40% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.29.
A look at the stock’s price movement, the close in the last trading session was $0.19, moving within a range at $0.265 and $0.4477. The beta value (5-Year monthly) was -0.463. Turning to its 52-week performance, $12.80 and $0.06 were the 52-week high and 52-week low respectively. Overall, CERO moved 225.68% over the past month.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
CERo Therapeutics Holdings Inc’s market cap currently stands at around $42.89 million, with investors looking forward to this quarter’s earnings report slated for in December.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CERO is a Hold. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
CERO’s current price about 144.34% and 176.22% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 73.34, while 7-day volatility ratio is 47.08% and 18.51% in the 30-day chart. Further, CERo Therapeutics Holdings Inc (CERO) has a beta value of 0.04, and an average true range (ATR) of 0.05.
If we refocus on CERo Therapeutics Holdings Inc (NASDAQ:CERO), historical trading data shows that trading volumes averaged 229.17 over the past 10 days and 43.56 million over the past 3 months. The company’s latest data on shares outstanding shows there are 51.35 million shares.
The 19.87% of CERo Therapeutics Holdings Inc’s shares are in the hands of company insiders while institutional holders own 4.20% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.6 million on 2024-10-31, giving us a short ratio of 0.29. The data shows that as of 2024-10-31 short interest in CERo Therapeutics Holdings Inc (CERO) stood at 208.0 of shares outstanding, with shares short falling to 2.32 million registered in 2024-09-30. Current price change has pushed the stock -97.41% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CERO stock continues to rise going into the next quarter.
